Boston Globe (subscription) |
Biotech startup to fight diabetes on the cellular front
Boston Globe (subscription) Anew Cambridge biotech will be working on a treatment using stem cells that could let children and adults with Type 1 diabetes do something their bodies currently cannot: produce their own insulin, the hormone that keeps blood sugar levels in balance. Semma Secures $44M to Develop Diabetes Stem Cell TherapyXconomy Semma Therapeutics Announces $44 Million in Funding Led by MPM Capital to …PharmiWeb.com (press release) all 7 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.